United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read General news updates Birla Corporation Q4 FY25: 33% profit surge sparks expansion drive amid sectoral tailwinds and market optimism Birla Corporation posts 33% Q4 profit jump and unveils ₹4,335 crore expansion. Analysts bullish as stock sentiment rebounds on capex and margin gains. byPallavi MadhirajuMay 12, 2025